Skip to textbook content
Doctor’s PassportTextbook
TopicsAll topics

Loading topic navigation…

Textbook navigation
TopicsAll topics

Loading topic navigation…

Educational draft · awaiting clinical reviewUse Rapid for revision, not patient-care decisions. Check current national and local guidance and the BNF or BNFC before acting.

Rapidly progressive dementia and Creutzfeldt-Jakob disease

Neurology · UK scope · Sources checked 27 Aug 2026 · Clinical review pending

RapidFull
!
Escalate

Cognitive decline over days to weeks with seizure, dysautonomia, fever, focal deficit, movement disorder, reduced consciousness or psychiatric change requires urgent hospital assessment for encephalitis, status epilepticus, metabolic or toxic disease and other treatable causes. Suspected CJD also needs immediate local infection-control and national prion-service advice before procedures involving high-risk tissue.

Synopsis

Treat rapid cognitive decline as an urgent syndrome, identify reversible inflammatory, infectious and toxic causes, and investigate possible prion disease with national specialist and infection-control support.

  • Rapidly progressive dementia evolves over weeks or months rather than years and is a diagnostic emergency because autoimmune, infectious, metabolic, toxic and neoplastic causes may be reversible.
  • First distinguish delirium, depression and non-convulsive status from a true progressive cognitive syndrome using attention, arousal, collateral timing and EEG where indicated.
  • Sporadic CJD commonly combines rapidly progressive cognitive decline with myoclonus, gait or limb ataxia, visual symptoms, pyramidal or extrapyramidal signs and later akinetic mutism.
  • MRI diffusion-weighted and ADC sequences may show cortical ribboning or caudate and putaminal diffusion restriction; the pattern must be reviewed by experienced neuroradiology.
  • CSF real-time quaking-induced conversion supports prion diagnosis with high specificity, while 14-3-3 and total tau reflect rapid neuronal injury and are less specific.
  • Periodic sharp-wave complexes on EEG can support sporadic CJD, but a normal or non-specific early EEG does not exclude disease and EEG is crucial for status epilepticus.
  • Autoimmune encephalitis, vasculitis, lymphoma, HIV or syphilis, Whipple disease, thyroid or B12 disease, drug toxicity and cancer-associated syndromes require history-led testing.
  • Contact the National Prion Clinic or National CJD Research and Surveillance Unit early rather than waiting for every result, and involve local infection prevention before biopsy or surgery.
  • There is no disease-modifying treatment for CJD; care prioritises clear communication, myoclonus and distress relief, nutrition, mobility, anticipatory planning and family support.

Key red flags

Prion phenotype

Rapid cognitive decline with myoclonus, cerebellar or visual dysfunction and pyramidal or extrapyramidal signs is characteristic of sporadic CJD but not pathognomonic.

Autoimmune encephalitis

Subacute memory loss, psychiatric change, new seizures, faciobrachial or other abnormal movements, dysautonomia or hyponatraemia should prompt urgent specialist autoimmune assessment.

Non-convulsive status

Fluctuating responsiveness, subtle twitching, gaze deviation or unexplained persistent confusion can represent ongoing seizure activity and requires urgent EEG-led treatment.

Toxic-metabolic pattern

Medicine change, organ failure, electrolyte disturbance, malnutrition or exposure with diffuse neurological dysfunction can produce a rapidly reversible encephalopathy.

Cortical and striatal diffusion

Restricted diffusion involving cerebral cortex or caudate and putamen in the appropriate pattern raises prion concern, while hypoxia, seizures and metabolic disease are imaging mimics.

Investigation priorities

01
Urgent MRI brain with DWI and ADCFirst step

Identify prion-associated cortical or striatal restriction and structural, inflammatory, vascular or neoplastic alternatives.

Management branches

First 24 hoursSearch first for reversible brain failure

Cognition and function have deteriorated substantially over weeks or a few months.

  1. Stabilise physiology, assess attention and consciousness, review medicines and toxins, obtain collateral chronology and treat seizures, sepsis, hypoglycaemia or suspected encephalitis without avoidable delay.
  2. Perform detailed neurological examination and urgent blood, MRI and EEG assessment, selecting lumbar puncture after structural and procedural safety review.
  3. Send CSF for routine, infectious, inflammatory, cytological and antibody tests shaped by phenotype while preserving samples for specialist additions.
  4. Engage neurology early because empirical antimicrobial or immunotherapy decisions and rapidly changing airway or autonomic risk exceed routine outpatient assessment.

Key medicines

Aciclovir for suspected viral encephalitisUse the local emergency intravenous weight- and renal-adjusted regimen immediately when herpes encephalitis remains plausible; do not await all CSF results.Ensure hydration and renal dose adjustment, monitor kidney function and intravenous access, and review continuation against PCR timing and specialist advice.
Clonazepam for distressing myoclonusBegin with a low specialist or palliative dose and titrate cautiously to comfort while preserving useful alertness where possible.Sedation, falls, aspiration and respiratory depression matter; review concurrent opioids or sedatives and distinguish symptomatic relief from seizure management.
Open full textbook →Answer 2 questions
Sources and review status5 sources · checked 27 Aug 2026 · clinical review pending+
Sources

Sources and review status

National guidance is shown before implementation-dependent detail. Typical adult dose examples remain subject to patient factors, contraindications and the live BNF or specialist protocol. Source check completed 27 Aug 2026; clinical approval remains outstanding.

  • National Prion ClinicUK expert diagnosis, CSF, genetics and family support pathway.
  • National CJD Research and Surveillance UnitUK surveillance, diagnostic criteria and clinician referral support.
  • ACDP transmissible spongiform encephalopathy guidanceCurrent tissue, instrument, laboratory and post-mortem infection-control guidance.
  • NICE NG127 suspected neurological conditionsUrgent recognition and referral for rapidly progressive neurological syndromes.
  • NICE NG97 dementia assessmentAlternative-cause assessment and specialist dementia diagnosis.

Editorial contact: Doctor’s Passport editorial team. Source-check date is separate from clinical approval. Report a content problem · Content changes

Authoring stateRapid draftClinical stateAwaiting reviewJurisdictionUnited Kingdom